Essex Woodlands IX, LLC
Insider CIK 1652286 · PSDV 10% owner · VERO 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| VERO Venus Concept Inc. | S Sale deriv | 2026-03-26 | 2026-03-27 | 1,500,000 | — | $0 | 0 | SEC↗ |
| VERO Venus Concept Inc. | S Sale deriv | 2026-03-26 | 2026-03-27 | 0 | — | $0 | 0 | SEC↗ |
| VERO Venus Concept Inc. | S Sale deriv | 2026-03-26 | 2026-03-27 | 1,575,810 | — | $0 | 0 | SEC↗ |
| VERO Venus Concept Inc. | P Buy deriv | 2024-01-18 | 2024-01-19 | 0 | — | $0 | 0 | SEC↗ |
| VERO Venus Concept Inc. | P Buy deriv | 2023-10-20 | 2023-10-20 | 502,513 | $3.98 | $2.00M | 1,575,810 | SEC↗ |
| VERO Venus Concept Inc. | P Buy deriv | 2023-09-08 | 2023-09-12 | 292,398 | $3.42 | $1.00M | 1,073,297 | SEC↗ |
| EYPT EyePoint Pharmaceuticals, | S Sale | 2023-09-01 | 2023-09-06 | 20,000 | $9.90 | $198.0K | 3,490,921 | SEC↗ |
| EYPT EyePoint Pharmaceuticals, | S Sale | 2023-09-01 | 2023-09-06 | 20,000 | $9.90 | $198.0K | 3,490,921 | SEC↗ |
| EYPT EyePoint Pharmaceuticals, | S Sale | 2023-08-31 | 2023-09-01 | 71,478 | $10.17 | $726.9K | 3,517,938 | SEC↗ |
| EYPT EyePoint Pharmaceuticals, | S Sale | 2023-08-31 | 2023-09-01 | 7,017 | $11.02 | $77.3K | 3,510,921 | SEC↗ |
| EYPT EyePoint Pharmaceuticals, | S Sale | 2023-08-30 | 2023-09-01 | 60,649 | $10.92 | $662.3K | 3,589,743 | SEC↗ |
| EYPT EyePoint Pharmaceuticals, | S Sale | 2023-08-30 | 2023-09-01 | 327 | $11.36 | $3.7K | 3,589,416 | SEC↗ |
| EYPT EyePoint Pharmaceuticals, | S Sale | 2023-08-29 | 2023-08-30 | 565 | $11.56 | $6.5K | 3,650,392 | SEC↗ |
| EYPT EyePoint Pharmaceuticals, | S Sale | 2023-08-29 | 2023-08-30 | 87,289 | $10.74 | $937.5K | 3,650,957 | SEC↗ |
| EYPT EyePoint Pharmaceuticals, | S Sale | 2023-08-28 | 2023-08-30 | 60,858 | $11.71 | $712.6K | 3,738,246 | SEC↗ |
| EYPT EyePoint Pharmaceuticals, | S Sale | 2023-08-25 | 2023-08-28 | 54,656 | $11.19 | $611.6K | 3,799,104 | SEC↗ |
| EYPT EyePoint Pharmaceuticals, | S Sale | 2023-08-25 | 2023-08-28 | 30,000 | $10.67 | $320.1K | 3,853,760 | SEC↗ |
| EYPT EyePoint Pharmaceuticals, | S Sale | 2023-08-25 | 2023-08-30 | 11,731 | $10.45 | $122.6K | 3,799,104 | SEC↗ |
| EYPT EyePoint Pharmaceuticals, | S Sale | 2023-08-25 | 2023-08-30 | 72,925 | $11.09 | $808.7K | 3,810,835 | SEC↗ |
| EYPT EyePoint Pharmaceuticals, | S Sale | 2023-08-24 | 2023-08-28 | 139,280 | $14.62 | $2.04M | 3,883,760 | SEC↗ |
| EYPT EyePoint Pharmaceuticals, | S Sale | 2023-08-24 | 2023-08-30 | 87,100 | $11.54 | $1.01M | 3,935,940 | SEC↗ |
| EYPT EyePoint Pharmaceuticals, | S Sale | 2023-08-24 | 2023-08-30 | 52,180 | $10.56 | $551.0K | 3,883,760 | SEC↗ |
| EYPT EyePoint Pharmaceuticals, | S Sale | 2023-08-23 | 2023-08-24 | 121,103 | $13.05 | $1.58M | 4,023,040 | SEC↗ |
| EYPT EyePoint Pharmaceuticals, | S Sale | 2023-08-22 | 2023-08-24 | 46,778 | $14.62 | $683.9K | 4,144,143 | SEC↗ |
| VERO Venus Concept Inc. | P Buy deriv | 2023-07-12 | 2023-07-13 | 500,000 | — | $0 | 780,899 | SEC↗ |
| VERO Venus Concept Inc. | P Buy deriv | 2023-05-15 | 2023-05-17 | 280,899 | $7.12 | $2.00M | 280,899 | SEC↗ |
| VERO Venus Concept Inc. | P Buy deriv | 2022-11-18 | 2022-11-22 | 1,441,985 | $2.00 | $2.88M | 1,441,985 | SEC↗ |
| VERO Venus Concept Inc. | P Buy deriv | 2022-11-18 | 2022-11-22 | 58,015 | $2.00 | $116.0K | 58,015 | SEC↗ |
| VERO Venus Concept Inc. | P Buy deriv | 2022-11-18 | 2022-11-22 | 1,441,985 | $2.00 | $2.88M | 1,441,985 | SEC↗ |
| VERO Venus Concept Inc. | P Buy deriv | 2022-11-18 | 2022-11-22 | 58,015 | $2.00 | $116.0K | 58,015 | SEC↗ |
| VERO Venus Concept Inc. | P Buy | 2021-12-15 | 2021-12-17 | 151,612 | $1.25 | $189.5K | 16,337,856 | SEC↗ |
| VERO Venus Concept Inc. | P Buy | 2021-12-15 | 2021-12-17 | 3,768,388 | $1.25 | $4.71M | 15,705,966 | SEC↗ |
| VERO Venus Concept Inc. | C Conversion deriv | 2020-06-16 | 2020-06-18 | 20,885 | — | $0 | 0 | SEC↗ |
| VERO Venus Concept Inc. | C Conversion deriv | 2020-06-16 | 2020-06-18 | 519,115 | — | $0 | 0 | SEC↗ |
| VERO Venus Concept Inc. | C Conversion | 2020-06-16 | 2020-06-18 | 208,853 | — | $0 | 12,417,856 | SEC↗ |
| VERO Venus Concept Inc. | C Conversion | 2020-06-16 | 2020-06-18 | 5,191,147 | — | $0 | 12,209,003 | SEC↗ |
| VERO Venus Concept Inc. | P Buy deriv | 2020-03-18 | 2020-03-20 | 3,893,360 | — | $0 | 3,893,360 | SEC↗ |
| VERO Venus Concept Inc. | P Buy deriv | 2020-03-18 | 2020-03-20 | 519,115 | $25.00 | $12.98M | 519,115 | SEC↗ |
| VERO Venus Concept Inc. | P Buy deriv | 2020-03-18 | 2020-03-20 | 156,640 | — | $0 | 156,640 | SEC↗ |
| VERO Venus Concept Inc. | P Buy deriv | 2020-03-18 | 2020-03-20 | 20,885 | $25.00 | $522.1K | 20,885 | SEC↗ |
| VERO Venus Concept Inc. | A Award deriv | 2019-11-07 | 2019-11-08 | 57,911 | — | $0 | 57,911 | SEC↗ |
| VERO Venus Concept Inc. | A Award deriv | 2019-11-07 | 2019-11-08 | 1,439,437 | — | $0 | 1,439,437 | SEC↗ |
| VERO Venus Concept Inc. | A Award deriv | 2019-11-07 | 2019-11-08 | 17,301 | — | $0 | 17,301 | SEC↗ |
| VERO Venus Concept Inc. | A Award | 2019-11-07 | 2019-11-08 | 128,827 | — | $0 | 3,330,880 | SEC↗ |
| VERO Venus Concept Inc. | A Award | 2019-11-07 | 2019-11-08 | 3,202,053 | — | $0 | 3,202,053 | SEC↗ |
| VERO Venus Concept Inc. | A Award | 2019-11-07 | 2019-11-08 | 2,104,941 | — | $0 | 5,435,821 | SEC↗ |
| VERO Venus Concept Inc. | A Award | 2019-11-07 | 2019-11-08 | 84,687 | — | $0 | 5,520,508 | SEC↗ |
| VERO Venus Concept Inc. | A Award | 2019-11-07 | 2019-11-08 | 1,439,437 | $3.75 | $5.40M | 6,959,945 | SEC↗ |
| VERO Venus Concept Inc. | A Award | 2019-11-07 | 2019-11-08 | 57,911 | $3.75 | $217.2K | 7,017,856 | SEC↗ |
| EYPT EyePoint Pharmaceuticals, | P Buy deriv | 2018-06-25 | 2018-07-03 | 652,244 | $1.27 | $828.3K | 16,864,066 | SEC↗ |
| EYPT EyePoint Pharmaceuticals, | P Buy deriv | 2018-06-25 | 2018-07-03 | 16,211,822 | $1.27 | $20.59M | 16,864,066 | SEC↗ |
| EYPT EyePoint Pharmaceuticals, | P Buy | 2018-06-25 | 2018-07-03 | 652,244 | $1.27 | $828.3K | 25,470,390 | SEC↗ |
| EYPT EyePoint Pharmaceuticals, | P Buy | 2018-06-25 | 2018-07-03 | 16,211,822 | $1.27 | $20.59M | 25,470,390 | SEC↗ |
| PSDV EyePoint Pharmaceuticals, | P Buy | 2018-03-28 | 2018-04-02 | 332,863 | $1.10 | $366.1K | 8,606,324 | SEC↗ |
| PSDV EyePoint Pharmaceuticals, | P Buy | 2018-03-28 | 2018-04-02 | 8,273,461 | $1.10 | $9.10M | 8,606,324 | SEC↗ |